Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04268888 |
| Title | Nivolumab in Combination With TACE/TAE for Patients With Intermediate Stage HCC (TACE-3) |
| Acronym | TACE-3 |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | The Clatterbridge Cancer Centre NHS Foundation Trust |
| Indications | |
| Therapies | |
| Age Groups: | child | senior | adult |
| Covered Countries | GBR |